Commentary for the Missing Data Working Group's perspective for regulatory clinical trials, estimands, and sensitivity analyses.

about

Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies.

P2860

Q39151736-A2CA8904-48AA-4C69-B8D1-5EDDB5A1AACB

P2860

Commentary for the Missing Data Working Group's perspective for regulatory clinical trials, estimands, and sensitivity analyses.

Item

http://www.wikidata.org/entity/Q36067041

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Commentary for the Missing Dat ...... nds, and sensitivity analyses.

@ast

Commentary for the Missing Dat ...... nds, and sensitivity analyses.

@en

type

Item

label

Commentary for the Missing Dat ...... nds, and sensitivity analyses.

@ast

Commentary for the Missing Dat ...... nds, and sensitivity analyses.

@en

prefLabel

Commentary for the Missing Dat ...... nds, and sensitivity analyses.

@ast

Commentary for the Missing Dat ...... nds, and sensitivity analyses.

@en

P1476

Commentary for the Missing Dat ...... nds, and sensitivity analyses.

@en

P2093

Gary G Koch

http://www.w3.org/2001/XMLSchema#string

P2860

A multiple imputation method for sensitivity analyses of time-to-event data with possibly informative censoring.

Sensitivity analysis for missing data in regulatory submissions.

A regulatory perspective on missing data in the aftermath of the NRC report.

Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.

Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.

A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.

Multicenter, placebo-controlled trial of lorcaserin for weight management.

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.

A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials.

Statistical considerations for design and analysis of a multiperiod crossover study to compare two treatments for migraine headache.

P304

2887-2893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SIM.6954

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laura E Wiener

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27374356

http://www.w3.org/2001/XMLSchema#string

Commentary for the Missing Data Working Group's perspective for regulatory clinical trials, estimands, and sensitivity analyses.

about

P2860

P2860

Commentary for the Missing Data Working Group's perspective for regulatory clinical trials, estimands, and sensitivity analyses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698